Stock Market Reviews

Read and share opinions on TLRY (Tilray Brands, Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock market.

Latest News

• Tilray Brands, Inc. (TLRY) Dips More Than Broader Market: What You Should Know
  Dec 30, 2025
• Tilray Brands, Inc. (TLRY)’s Potential Upside Meets a Cautious Consensus
  Dec 27, 2025
• Tilray Brands, Inc. (TLRY) Stock Falls Amid Market Uptick: What Investors Need to Know
  Dec 22, 2025
• Tilray Brands to Announce Second Quarter Fiscal Year 2026 Financial Results on January 8, 2026
  Dec 22, 2025
• Why Tilray (TLRY) Stock Is Trading Lower Today
  Dec 19, 2025
• Jim Cramer on Tilray: “What They Lack Is Earnings”
  Dec 19, 2025

TLRY News

• Tilray Brands, Inc. (TLRY)’s Potential Upside Meets a Cautious Consensus
  Tilray Brands, Inc. (NASDAQ:TLRY) is among the Best Get Rich Fast Stocks to Buy Right Now. As of December 24, Tilray Brands, Inc. (NASDAQ:TLRY) has mixed analyst sentiment, with slightly more than 60% of analysts covering the stock assigning a Hold rating and the remaining 36% recommending buying the stock. While the target price ranges […]
  Dec 27, 2025
• This Stock Has Almost Tripled in 6 Months. Here's What Investors Need to Watch Next
  Is it too late to jump on the bandwagon?
  Dec 24, 2025
• Everything Investors Need to Know About President Trump's Executive Order Reclassifying Marijuana as a Lower Class of Drug
  President Donald Trump just signed an executive order that reclassified marijuana from a Schedule I narcotic to Schedule III.
  Dec 23, 2025
• President Trump Just Reclassified Marijuana. Are Green Thumb, Tilray, and Trulieve Stocks No-Brainer Buys?
  These cannabis companies could soon see more green thanks to the president's milestone decision.
  Dec 23, 2025
• Tilray Brands, Inc. (TLRY) Stock Falls Amid Market Uptick: What Investors Need to Know
  In the most recent trading session, Tilray Brands, Inc. (TLRY) closed at $10.42, indicating a -6.63% shift from the previous trading day.
  Dec 22, 2025
• Is Tilray Brands Fairly Priced After Recent Rally and Discount to Sales Peers in 2025?
  Wondering if Tilray Brands is finally priced for a turnaround or still just a speculative cannabis play? Let us unpack what the current share price is really implying about its future. Tilray’s stock has bounced about 2.1% over the last week and a hefty 23.2% over the past month, even though it remains down 23.6% year to date and about 22.0% over the last year, with a much steeper 60.0% slide over three years. Those moves are happening against a backdrop of ongoing cannabis sector...
  Dec 22, 2025
• Tilray Brands to Announce Second Quarter Fiscal Year 2026 Financial Results on January 8, 2026
  NEW YORK and LEAMINGTON, Ontario, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the cannabis, beverage and wellness industries, today announced that the Company will release its financial results for the second fiscal quarter which ended November 30, 2025, after the financial markets close on Thursday, January 8, 2026. Live Conference Call and Audio Webcast Ti
  Dec 22, 2025
• Why Tilray (TLRY) Stock Is Trading Lower Today
  Shares of cannabis company Tilray Brands (NASDAQ:TLRY) fell 9% in the afternoon session after the company's stock fell in a 'buy the rumor, sell the news' reaction as the U.S. government moved to reschedule cannabis.
  Dec 19, 2025
• Jim Cramer on Tilray: “What They Lack Is Earnings”
  Tilray Brands, Inc. (NASDAQ:TLRY) is one of the stocks Jim Cramer was asked about. When a caller asked about the stock during the lightning round, Cramer stated: “It’s a kaching kaching. I want you to sell half, and if they approve it, then you sell the other half. You see, because what they lack is […]
  Dec 19, 2025
• Is Tilray Brands Stock a Buy, Sell, or Hold in 2026?
  The cannabis stock has been rallying on hopes of marijuana rescheduling finally taking place in the U.S.
  Dec 19, 2025
• Why Tilray Stock Dropped This Week, Even After President Trump's Executive Order
  Why did Tilray's 30% gain evaporate this week?
  Dec 19, 2025
• Cannabis Stocks Recovering Premarket
  U.S. cannabis stocks were rising in premarket trading after President Donald Trump signed an executive order asking the U.S. government to reclassify the substance as less dangerous. Investors took profits on the executive order, but some gains recovered premarket. A basket of cannabis stocks—represented by the AdvisorShares Pure US Cannabis exchange-traded fund—rose 5.7% premarket after closing down 29% Thursday.
  Dec 19, 2025
• Cannabusiness Prospects Light Up as White House Reclassifies Marijuana
  President Trump's executive order changing the classification of marijuana could lower taxes for some businesses and prompt new research.
  Dec 19, 2025
• Trump’s Marijuana Order Isn’t Helping Cannabis Stocks
  Cannabis stocks remain under pressure after President Donald Trump signed an executive order Thursday directing the Department of Justice to reschedule marijuana as a lower-class drug. The Department of Justice’s proposed rule, first issued in May 2024, will reclassify marijuana as a Schedule III drug from Schedule I but doesn’t permit legalized recreational sales. Other Schedule I substances include highly addictive drugs with no accepted medical use, such as heroin, while Schedule III substances are considered to have lower potential for abuse.
  Dec 19, 2025
• Nike, Tilray, and Palantir: Their Unusually Active Put Options Will Boost Your Wallet After Christmas
  Christmas has gotten more expensive this year due to inflation and tariffs. Americans of all stripes can use a break. These six unusually active put options from Thursday trading could boost your wallet the day after Christmas. Ho. Ho. Ho!
  Dec 19, 2025
• BC-Most Active Stocks
  Nu Holdings Ltd. 39,065,865 16.3555
  Dec 18, 2025
• Tilray Brands, Inc. (TLRY): A Bear Case Theory
  We came across a bearish thesis on Tilray Brands, Inc. on The Dutch Investors’s Substack. In this article, we will summarize the bulls’ thesis on TLRY. Tilray Brands, Inc.’s share was trading at $12.88 as of December 18th. TLRY’s trailing P/E was 57.50 according to Yahoo Finance. Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle […]
  Dec 18, 2025
• TSX Closer: Up For the First Session In Five; Cannabis Stocks Stumble As U.S. Reclassification of Marijuana Becomes a Fact
  The Toronto Stock Exchange closed higher on Thursday for the first time in five sessions, largely on
  Dec 18, 2025
• Stocks making big moves yesterday: Broadcom, Olaplex, Paycom, Tilray, and Workiva
  Check out the companies making headlines yesterday:
  Dec 18, 2025
• Micron soars, cannabis stocks pop on Trump's executive order
  Yahoo Finance host Josh Lipton tracks today's top moving stocks and biggest market stories in this Market Minute, including Micron Technology (MU) stock soaring due to high demand on its high-bandwidth memory chips and cannabis stocks Canopy Growth (CGC) and Tilray Brands (TLRY) rising after President Trump signed an executive order to expedite the reclassification of marijuana to a Schedule III drug. Stay up to date on the latest market action, minute-by-minute, with Yahoo Finance's Market Minute.
  Dec 18, 2025
• Cloud lifts over cannabis companies' future amid push to reclassify the drug
  Cannabis companies like Tilray Brands and Canopy Growth could soon face a more mellow path ahead following President Donald Trump's move to help reclassify the drug's status. The companies had a mostly muted reaction to Trump's executive order, though the sector has been gaining ground since last week in anticipation of the move. Trump's executive order would speed up the Drug Enforcement Administration's process that would shift the drug's current classification as a Schedule I drug, alongside heroin and LSD.
  Dec 18, 2025
• Trump signs EO to reschedule marijuana, but a few hurdles remain
  President Trump has signed an executive order to expedite the rescheduling of marijuana from a Schedule I drug to a less-severe Schedule III drug. Yahoo Finance Senior Producer John Hyland joins Market Domination Overtime host Josh Lipton to explain what we know. To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime.
  Dec 18, 2025
• Tilray Accelerates U.S. Medical Cannabis Expansion After Landmark Federal Rescheduling: Launches Tilray Medical USA to Lead Nationwide Medical Cannabis Innovation and Growth
  Global Cannabis Leader Poised for Major U.S. Market Entry, Signaling New Era for HealthcareNEW YORK, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Tilray Medical, a division of Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY) and a global leader in medical cannabis healthcare, today confirmed its planned strategic framework to advance its U.S. medical cannabis operations following federal cannabis rescheduling and related regulatory developments. In conjunction with these regulatory
  Dec 18, 2025
• Wall Street Rebounds Following Cooler-Than-Expected Consumer Inflation
  The S&P 500 and the Dow Jones Industrial Average snapped a four-day slump on Thursday after data sho
  Dec 18, 2025
• Trump Signs Marijuana Reclassification Order, Paving Way For Medical Research
  US President Donald Trump on Thursday signed an executive order to ease restrictions on marijuana in
  Dec 18, 2025
• Tilray and Cannabis Stocks Fall as Trump Reschedules Marijuana
  Cannabis stocks fell Thursday after President Donald Trump signed an executive order to reschedule marijuana as a lower-class drug. Trump’s order reclassifies marijuana as a Schedule III drug from Schedule I, but doesn’t permit legalized recreational sales. Other Schedule I substances include highly addictive drugs with no accepted medical use, such as heroin, while Schedule III substances are considered to have lower potential for abuse.
  Dec 18, 2025
• These Stocks Moved the Most Today: Micron, DJT, Accenture, Tilray, Lululemon, Medline, Rivian, and More
  Shares in memory-chip makers Micron and Sandisk rally after Micron tops Wall Street's earnings estimates.
  Dec 18, 2025
• Stock Market Today, Dec. 18: Tilray Brands Jumps After Trump Order Spurs Cannabis Rescheduling
  Today, Dec. 18, 2025, investors are weighing Tilray’s fresh U.S. medical push and sector volatility after federal cannabis rescheduling.
  Dec 18, 2025
• Why Tilray (TLRY) Shares Are Falling Today
  Shares of cannabis company Tilray Brands (NASDAQ:TLRY) fell 5.2% in the afternoon session after the stock gave back some of its recent gains, which were fueled by reports that the U.S. administration was considering reclassifying marijuana.
  Dec 17, 2025
• Pot stocks pop on Schedule 3 hopes: Tilray Brands, Trulieve Cannabis, Cresco Labs: How high will they go?
  President Trump has hinted that he might lessen restrictions through an executive order, although no official announcement has yet been made.
  Dec 17, 2025
• OrganiGram (OGI) Reports Q4 Loss, Beats Revenue Estimates
  OrganiGram (OGI) delivered earnings and revenue surprises of -1,900.00% and +7.10%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
  Dec 16, 2025
• Why Tilray Stock Soared 27.5% Today
  President Trump just gave cannabis investors something they've been waiting for.
  Dec 16, 2025
• Explainer-How US marijuana reclassification could help cannabis companies
  Dec 15 (Reuters) - U.S. President Donald Trump said he is considering signing an executive order to reclassify marijuana as a less dangerous drug, though he offered no timeline for the move.
  Dec 16, 2025
• Trump’s Giving Cannabis Stocks a Lift—and the Optimism May Be Justified
  After many false starts, investors are once again betting that marijuana businesses are close to seeing federal restrictions ease.
  Dec 16, 2025
• Option Traders Are Pricing a Nearly 22% Move in Tilray Stock Before the End of 2025. Should You Buy, Sell, or Hold TLRY Here?
  Tilray stock soared today after President Donald Trump signalled reclassification of cannabis as a Schedule III drug in the near-term. Here’s what that means for TLRY shares heading into 2026.
  Dec 16, 2025
• Stock Market Today, Dec. 16: Tilray Brands Surges 27.5% After Trump Signals Possible Marijuana Reclassification
  Tilray’s jump in a broad cannabis rally shows how shifting U.S. policy signals are jolting traders, today, Dec. 16, 2025.
  Dec 16, 2025
• Why Tilray Brands, Inc. (TLRY) Dipped More Than Broader Market Today
  In the latest trading session, Tilray Brands, Inc. (TLRY) closed at $10.93, marking a -10.04% move from the previous day.
  Dec 15, 2025
• Tilray CEO says THC drink regulation will benefit cannabis companies
  President Trump is expected to sign an executive order that could reclassify marijuana from a Schedule I to a Schedule III drug, which would enable cannabis to be federally classified for medical use. Tilray Brands (TLRY) Chairman and CEO Irwin Simon sits down with Julie Hyman to share his outlook on his company's THC and hemp products in relation to Congress' latest budget bill that could see a ban on most hemp-derived THC products by late 2026. To watch more expert insights and analysis on the latest market action, check out more Market Catalysts.
  Dec 15, 2025
• Tilray Brands, Inc. (TLRY) Just Overtook the 200-Day Moving Average
  Should investors be excited or worried when a stock crosses above the 200-day simple moving average?
  Dec 15, 2025
• Why Tilray Stock Plunged Today
  The legal status of marijuana in the U.S. remains scattered and confusing.
  Dec 15, 2025
• Tilray Brands (TLRY) Cuts Float and Regains Nasdaq Compliance With Reverse Split
  Tilray Brands, Inc. (NASDAQ:TLRY) ranks among the best sin stocks to buy in 2026. On December 4, TD Cowen reaffirmed its Buy rating on Tilray Brands, Inc. (NASDAQ:TLRY) but reduced its price target to $10 from $25 for the cannabis and beverage company . According to TD Cowen analyst Robert Moskow, the adjustment takes into […]
  Dec 15, 2025
• Tilray Brands, Inc. (TLRY) Crossed Above the 20-Day Moving Average: What That Means for Investors
  Good things could be on the horizon when a stock surpasses the 20-day simple moving average. How should investors react?
  Dec 15, 2025
• Cannabis stocks pull back, IMAX upgraded to Overweight
  Yahoo Finance host Josh Lipton tracks today's top moving stocks and biggest market stories in this Market Minute, including cannabis stocks like Tilray Brands (TLRY) and Canopy (CGC) pulling back ahead of expectations for President Trump to sign an executive order reclassifying marijuana to a Schedule III drug, and JPMorgan analysts upgrading IMAX (IMAX) shares to an Overweight rating. Stay up to date on the latest market action, minute-by-minute, with Yahoo Finance's Market Minute.
  Dec 15, 2025
• Tilray Brands Soars on Reports of Likely US Marijuana Reclassification
  TLRY surges 44.1% on reports that Trump may reclassify marijuana, sparking hopes for eased federal rules and renewed investor enthusiasm.
  Dec 15, 2025
• Cannabis Stocks Drop. Will Trump Reclassify Marijuana Today?
  Marijuana stocks surged Friday after reports that Trump could sign an executive order reclassifying cannabis.
  Dec 15, 2025
• These Stocks Are Moving the Most Today: iRobot, Tesla, ServiceNow, Tilray, Rocket Lab, Strategy, Zillow, and More
  Roomba maker iRobot plummets following a bankruptcy filing, while cannabis stocks decline following sharp gains Friday after reports of possible looser marijuana restrictions.
  Dec 15, 2025
• The Rally for Cannabis Stocks Grinds to a Halt Amid Uncertainty About Trump Order
  Weed stocks dropped Monday, reversing early gains on hopes President Trump could soon issue an executive order reclassifying marijuana.
  Dec 15, 2025
• As Trump Considers Signing a Cannabis Executive Order, Should You Buy the Dip in Tilray Stock?
  Down almost 98% from all-time highs, Tilray is a Canada-based cannabis stock that surged over 40% on Friday.
  Dec 15, 2025
• Want to Jump on the Cannabis Stocks Rally? This Company Has Been the Top-Performing Player in 2025.
  Down almost 70% from all-time highs, Curaleaf stock offers significant upside potential given its widening free cash flow margins.
  Dec 15, 2025
• Why Tilray Stock Soared This Week
  The cannabis business might soon be a lot more lucrative.
  Dec 14, 2025
• Are Tilray Brands' (TLRY) Vape and Holiday Drink Push Reshaping Its Margin Story?
  Earlier this month, Tilray Brands’ Redecan unit launched Amped Live Resin Liquid Diamond 1g 510 vape cartridges in Canada, while Tilray also promoted a broad 2025 holiday drink gift guide across its craft beer, spirits, RTD cocktails, and hemp-derived THC beverage portfolio in North America. The new Amped live resin–liquid diamond line highlights Tilray’s push into higher-value cannabis vape formats, while the holiday beverage campaign underscores how its diversified alcohol and THC drink...
  Dec 14, 2025
• Tilray (TLRY) Valuation Check After New Vape Launch and Florida Home-Grow Cannabis Bill Progress
  Tilray Brands (TLRY) has been back on traders radar after a 12% jump this week, as Florida moved ahead with a home grow cannabis bill and the company unveiled its new Amped Live Resin Liquid Diamond vape line. See our latest analysis for Tilray Brands. Those headlines are landing on a stock that has been extremely volatile, with a 65.31% 7 day share price return and 2.10% 1 year total shareholder return hinting that momentum is only just starting to rebuild after a tougher stretch. If...
  Dec 13, 2025
• Trump expected to sign EO to reclassify marijuana as soon as Monday, CNBC says
  Cannabis stocks jumped on Friday following reports that President Donald Trump will significantly ease federal restrictions on marijuana, with an executive order seen as coming as soon as Monday, CNBC’s Alex Harring and Brandon Gomez report. Trump is expected to use an executive order to instruct federal agencies to reclassify marijuana as a less regulated Schedule III drug from a Schedule I, the Washington Post reported on Thursday. Such a move would allow cannabis companies to fall under diffe
  Dec 13, 2025
• BC-Most Active Stocks
  Nu Holdings Ltd. 36,506,840 17.06
  Dec 12, 2025
• S&P 500, Dow Retreat From Record Amid Broadcom-Led Tech Selloff
  The S&P 500 and the Dow Jones Industrial Average retreated from record highs as margin concerns faci
  Dec 12, 2025
• TSX Down 250 Points With Info Tech, Miners, The Worst Performers, Cannabis Stocks Surge
  The Toronto Stock Exchange was down 250 points midday on Friday with tech, down 4%, and miners, down
  Dec 12, 2025
• Why Tilray Stock Lit Up Today
  President Trump just delivered an early Christmas gift to Tilray.
  Dec 12, 2025
• Tilray (TLRY) Shares Skyrocket, What You Need To Know
  Shares of cannabis company Tilray Brands (NASDAQ:TLRY) jumped 40.8% in the afternoon session after reports suggested the Trump administration planned to ease federal restrictions on marijuana by reclassifying it as a less dangerous substance.
  Dec 12, 2025
• Top Midday Stories: Broadcom Falls Amid Gross Profit Margin Concern; Nasdaq's Listing Rule Proposal; Oracle Revises Timeline for OpenAI Data Centers
  All three major US stock indexes were edging lower in midday trading on Friday as Broadcom's (AVGO)
  Dec 12, 2025
• Cannabis stocks climb as Trump weighs marijuana rescheduling
  Investing.com -- Cannabis stocks surged Friday after reports that President Donald Trump is considering directing his administration to reclassify marijuana as a less dangerous drug, potentially marking a significant shift in U.S. policy.
  Dec 12, 2025
• Cannabis stocks surge on report Trump seeks to ease restrictions
  <body><p>STORY: Shares of cannabis companies soared on Friday after a report said President Donald Trump is looking to dramatically loosen federal restrictions on marijuana.</p><p>The Washington Post a day earlier reported that Trump plans to direct federal agencies to reclassify pot as a Schedule III drug.</p><p>It is currently listed as a Schedule I substance, meaning it has a high potential for abuse and no currently accepted medical use.</p><p>A shift to Schedule III would reduce oversight of the plant and its derivatives to the same level as some common prescription painkillers and other drugs.</p><p>Investors reacted quickly to the news, with U.S.-listed shares of cannibis company Tilray Brands skyrocketing more than 44%, while shares of SNDL, Canopy Growth and ETF AdvisorShares Pure US Cannabis were up between 24% and 39% in Friday morning trading.</p><p>The reclassification could also ease criminal penalties regarding marijuana, and reshape the industry through potentially lower taxes and easier means of funding.</p><p>Funding remains one of the biggest challenges for cannabis producers, as federal restrictions keep most banks and institutional investors out of the sector, forcing producers to turn to costly loans or alternative lenders.</p><p>The Drug Enforcement Administration has to review the recommendation and will decide on the reclassification.</p></body>
  Dec 12, 2025
• Cannabis Stocks Soar as Trump Reportedly Seeks to Ease Restrictions on Marijuana
  Shares of cannabis companies surged on Friday following reports that US President Donald Trump was s
  Dec 12, 2025
• Equity Markets Fall Intraday as Broadcom Weighs on Tech Sector
  US benchmark equity indexes were lower intraday as the technology sector tumbled amid a post-earning
  Dec 12, 2025
• Sector Update: Consumer Stocks Advance Friday Afternoon
  Consumer stocks rose Friday afternoon, with the State Street Consumer Staples Select Sector SPDR ETF
  Dec 12, 2025
• Sector Update: Consumer Stocks Rise Late Afternoon
  Consumer stocks advanced late Friday afternoon, with the State Street Consumer Staples Select Sector
  Dec 12, 2025
• Trump headlines boost cannabis stocks, RH rises on Q3 earnings
  Morning Brief host Julie Hyman takes a look at some of Friday's trending tickers, including Fermi (FRMI), RH (RH), and cannabis stocks — Tilray (TLRY), Canopy (CGC), Aurora (ACB), and SNDL Inc (SNDL). To watch more expert insights and analysis on the latest market action, check out more Morning Brief.
  Dec 12, 2025
• These Stocks Moved the Most Today: Broadcom, Oracle, Fermi, Tilray, Lululemon, Costco, Netskope, and More
  Broadcom falls sharply after reporting earnings, Oracle extends losses, and Lululemon beats analysts’ estimates for third-quarter earnings and revenue.
  Dec 12, 2025
• Cannabis Stocks Surge. Trump May Reclassify Marijuana—but White House Says a Final Decision Hasn’t Been Made.
  Cannabis stocks Tilray Brands and Canopy Growth surged following reports that President Donald Trump would loosen federal restrictions on marijuana. A White House official told Barron’s that no final decision had been made regarding the rescheduling of the drug. The president indicated as far back as August that he was weighing the positives and negatives of a policy change.
  Dec 12, 2025
• Stocks to Watch Friday Recap: Broadcom, Lululemon, Tilray Brands
  ↘️ Broadcom (AVGO): Concerns about the chip maker's sales forecasts, contracts backlog and anticipated future margins overshadowed its rapid revenue growth. Shares closed 11% lower. ↗️ Lululemon (LULU): Calvin McDonald will step down in January as CEO of the athletic gear maker, which has been under pressure from its founder to make changes to reverse its “loss of cool.
  Dec 12, 2025
• Trump Lights Up the Cannabis Market With Plans for Reclassification
  The U.S. marijuana industry has stagnated for year, languishing under federal inaction on reclassification or decriminalization. Classified as a Schedule I drug under the Controlled Substances Act — alongside hard drugs like heroin and LSD — cannabis is deemed to have no accepted medical use and high abuse potential. This status blocks research, interstate commerce, ... Trump Lights Up the Cannabis Market With Plans for Reclassification
  Dec 12, 2025
• Marijuana Stocks Are Soaring Friday on Anticipation Trump Could Soon Make This Change
  Cannabis stocks surged Friday following reports President Donald Trump could soon reclassify marijuana as a less dangerous substance.
  Dec 12, 2025
• Stock Market Live December 12: Trump to Ease Marijuana Regulation, S&P 500 (VOO) Flat
  This article will be updated throughout the day, so check back often for more daily updates. The Vanguard S&P 500 ETF (NYSEMKT: VOO) ended up gaining a modest 0.25% on Thursday, one day after the Federal Reserve cut interest rates by the expected… 0.25%. Just a coincidence, I’m sure. And it’s a coincidence, too, that ... Stock Market Live December 12: Trump to Ease Marijuana Regulation, S&P 500 (VOO) Flat
  Dec 12, 2025
• Redecan Cannabis Brand Elevates the Diamond Vape Category with the Launch of Amped Live Resin Liquid Diamond Vapes
  TORONTO, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the cannabis, beverage and wellness industries, announces the launch of Amped Live Resin Liquid Diamond 1g 510 cartridges, marking Redecan’s first live resin–liquid diamond line for the brand. The debut lineup, Space Age CK and Blueberry DNTS, pairs Redecan’s Legit Live Resin with Liquid Diamonds to deliver a true‑to‑strai
  Dec 11, 2025
• Here Are Thursday’s Top Wall Street Analyst Research Calls: American Eagle Outfitters, Ferrari, Intuitive Surgical, Roku, PayPal, Synopsis, Visa, and More
  Pre-Market Stock Futures: Futures are trading lower after a big rate-cut rally on Wednesday was sideswiped by Oracle’s disappointing earnings after the bell yesterday. The Federal Reserve’s 25-basis-point rate cut, as expected, put the benchmark rate at 3.50%-3.75%. The third consecutive cut lowered rates to their lowest level since late 2022, to help support a ... Here Are Thursday’s Top Wall Street Analyst Research Calls: American Eagle Outfitters, Ferrari, Intuitive Surgical, Roku, PayPal, Sy
  Dec 11, 2025
• Tilray Brands (TLRY) Goes 12.36% High as Senator Files New Cannabis Bill
  We recently published Small But Savage: 10 Stocks Delivering Outsized Gains. Tilray Brands, Inc. (NASDAQ:TLRY) is one of the best performers on Tuesday. Tilray Brands bounced back by 12.36 percent on Tuesday to close at $8.09 apiece as investor optimism was bolstered by the submission of a new Senate bill, which aims to legalize home […]
  Dec 10, 2025
• Cronos Group Plans Strategic Europe Expansion: How to Play the Stock?
  CRON's planned CanAdelaar acquisition boosts its push into the Dutch adult-use cannabis market and highlights its strengthening international momentum.
  Dec 10, 2025
• Is Tilray A Bargain After Its 50% Slide Amid Cannabis Legislation Shifts?
  Wondering if Tilray Brands at around $7.35 is a bargain or a value trap? This breakdown will walk you through what the current price really implies. The stock has been volatile lately, dropping about 9.6% over the last week, 40.7% over the past month, and 49.7% year to date. This has left many investors questioning whether the recent weakness is an opportunity or a warning sign. Recent headlines have focused on shifting cannabis legislation in key markets and Tilray’s ongoing push to...
  Dec 8, 2025
• Tilray Brands, Inc. (TLRY) Suffers a Larger Drop Than the General Market: Key Insights
  The latest trading day saw Tilray Brands, Inc. (TLRY) settling at $7.2, representing a -2.04% change from its previous close.
  Dec 8, 2025
• This Stock-Split Stock Is Up 90% in the Past 6 Months: Is There More Upside Ahead?
  Don't bet on it.
  Dec 6, 2025
• 3 Cash-Burning Stocks with Warning Signs
  Rapid spending isn’t always a sign of progress. Some cash-burning businesses fail to convert investments into meaningful competitive advantages, leaving them vulnerable.
  Dec 5, 2025
• Why Tilray Stock Dived by 10% This Week
  A financial engineering move and an analyst's price target cut dampened sentiment on the company.
  Dec 5, 2025
• Is There a Future for Tilray Brands?
  It may be time for investors to cut their losses.
  Dec 4, 2025
• 2025 Cannabis Holiday Gift Guide Highlights Canada’s Most Popular Cannabis Products for the Holiday Season
  TORONTO, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc., company (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the cannabis, beverage, and wellness industries, today released its 2025 Cannabis Holiday Gift Guide, showcasing Canadians’ top picks for gifting, entertaining, and seasonal celebrations. With cannabis now firmly embedded in Canada’s holiday culture, the guide arrives ahead of one of the industry’s busiest retail
  Dec 4, 2025
• Tilray Releases the Ultimate 2025 Holiday Drink Gift Guide, Celebrating Seasonal Sips and Moments of Connection from Coast to Coast
  ATLANTA, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc., company (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the beverage, cannabis and wellness industries, is pleased to unveil the Ultimate 2025 Holiday Drink Gift Guide—a curated collection of the season’s most giftable craft beers, premium spirits, ready-to-drink cocktails, and hemp-derived beverages designed to elevate gatherings and spark moments of connection across
  Dec 4, 2025
• Down 66% From Its High, Can Tilray Brands Stock Turn Things Around?
  At one point this year, the cannabis producer's stock was up as much as 58%.
  Dec 4, 2025
• TLRY Stock Loses 38% in a Month: Should You Buy the Dip?
  Tilray's slump deepens as a tighter U.S. hemp rule and a reverse split stir uncertainty despite gains in global cannabis sales.
  Dec 3, 2025
• Tilray implements stock-split plan
  The North American business had halted plans to reduce the number of market-traded shares in June.
  Dec 1, 2025
• Tilray Brands, Inc. (TLRY) Registers a Bigger Fall Than the Market: Important Facts to Note
  Tilray Brands, Inc. (TLRY) closed the most recent trading day at $0.78, moving 3.76% from the previous trading session.
  Dec 1, 2025
• What a Hemp Crackdown in the U.S. Could Mean for Tilray's Growth Opportunities
  By November 2026, hemp-based THC products could be controlled substances.
  Nov 30, 2025
• A Fresh Look at Tilray Brands (NASDAQ:TLRY) Valuation After Recent Share Price Drop
  Tilray Brands (NASDAQ:TLRY) has caught attention lately as investors reflect on its recent stock movements and broader performance trends. With ongoing sector shifts, the company’s results are stirring renewed conversations about valuation and future trajectory among market watchers. See our latest analysis for Tilray Brands. Tilray Brands shares have tumbled sharply in recent weeks, with the 1-day share price return of -21.07% adding to a string of declines that have driven the 30-day share...
  Nov 29, 2025
• BC-Most Active Stocks
  HIVE Digital Technologies Ltd. 17,662,972 3.555
  Nov 28, 2025
• Why Tilray Stock Just Stubbed Out
  In a clear sell signal, Tilray will reverse split its stock next week.
  Nov 28, 2025
• US Equity Markets Close Higher During Thanksgiving Week as Interest Rate Cut Expectations Remain Strong
  US equity indexes closed higher Friday despite a losing month amid broad market gains during the Tha
  Nov 28, 2025
• Why Tilray (TLRY) Shares Are Plunging Today
  Shares of cannabis company Tilray Brands (NASDAQ:TLRY) fell 16.4% in the after-market session after the company announced it would implement a 1-for-10 reverse stock split. A reverse stock split combines multiple shares into one, which increases the price per share without changing the company's total value. Although management noted the move was intended to make the company more attractive to institutional investors and cut up to $1 million in yearly administrative costs, investors reacted nega
  Nov 28, 2025
• Exchange-Traded Funds Edge Higher, Equity Futures Frozen Pre-Bell Friday as CME Outage Slowly Resolves
  The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was up 0.2% and the actively trad
  Nov 28, 2025
• Top Midday Stories: Jefferies Under SEC Probe; Qwant Complaint Against Microsoft Dismissed; Oracle, Vantage Seek $38 Billion for OpenAI Sites
  All three major US stock indexes rose in midday trading Friday after the Chicago Mercantile Exchange
  Nov 28, 2025
• Tilray Brands stock split, Sandisk joins S&P 500, retailers rise
  Market Catalysts host Julie Hyman tracks several of the day's top trending stock tickers, including Tilray Brands (TLRY), Sandisk (SNDK), and retailers such as Amazon (AMZN), Target (TGT), and Walmart (WMT). To watch more expert insights and analysis on the latest market action, check out more Market Catalysts.
  Nov 28, 2025
• Tilray Brands Strengthens Domestic Lead With Strong Q1 Cannabis Growth
  TLRY posts a strong quarter as Canadian cannabis revenues grow and market shares climb across key product categories.
  Nov 28, 2025
• Chicago Mercantile Exchange Restarts After Data Center Disruption
  The Chicago Mercantile Exchange restored most trading operations after an hours-long outage stemming from problems at a data center. Shares of CME Group (CME) dipped in the premarket session on the news. We're also watching: - Shares of Tilray Brands (TLRY) fell ahead of the US market open after the cannabis company announced that it will implement a one-for-ten reverse stock split of its common stock. - Shares of Oracle (ORCL) declined in early trading after Morgan Stanley warned a gauge of risk on Oracle Corp.'s debt reached a three-year high in November. Lisa Mateo reports.
  Nov 28, 2025
• Tilray Plunges Ahead of a 1-for-10 Reverse Stock Split. Here's What You Need to Know
  Tilray Brands shares tumbled Friday ahead of a reverse stock split set set to take effect after markets close next Monday, Dec. 1.
  Nov 28, 2025
• Did Tilray’s (TLRY) Quebec Vape Launch Just Shift Its Long-Term Growth Narrative?
  Tilray Brands, Inc. recently announced the launch of Good Supply's cannabis vape products in Quebec, introducing 1 g 510-thread cartridges in Pineapple Express (Hybrid) and Blue Dream (Sativa) for both in-store and online sales under the new provincial legalization of cannabis vaping. This development marks a significant step for Tilray in expanding its product portfolio and accessing the newly opened Quebec cannabis vape market, reflecting evolving provincial regulatory trends. We'll...
  Nov 26, 2025
• Cannabis stocks rise as US Medicare reportedly considers CBD coverage
  Investing.com -- Cannabis stocks gained Wednesday following an article from Bloomberg reporting that the US Medicare program may soon cover CBD treatments for certain patients, providing a potential new revenue stream for the industry.
  Nov 26, 2025
• Tilray Brands Announces Implementation of Previously Approved 1-for-10 Reverse Stock Split
  Common Stock Expected to Begin Trading on a Split-Adjusted Basis on December 2, 2025NEW YORK, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray Brands”, “Tilray” or “the Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the global cannabis, beverage, and wellness industries, today announced that it will implement a one-for-ten reverse stock split of the Company’s common stock (the “Reverse Stock Split”), as previously app
  Nov 26, 2025
• Tilray Brands, Inc. (TLRY) Exceeds Market Returns: Some Facts to Consider
  Tilray Brands, Inc. (TLRY) reached $0.98 at the closing of the latest trading day, reflecting a +1.89% change compared to its last close.
  Nov 25, 2025
• Tilray Unveils Good Supply Vapes in Québec Following the Recent Introduction of Vape Products in Québec
  TORONTO, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc., company (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the cannabis, beverage, and wellness industries, today announced the introduction of Good Supply vape products in Québec as part of the launch of legal cannabis vaping products in Québec. Consumers in Québec will now have access to Good Supply’s acclaimed vape products, as the brand introduces its popular 1 g 510‑
  Nov 24, 2025
• TLRY vs. CRLBF: Which Cannabis Player Offers Greater Upside?
  Tilray Brands' global expansion and strong Canadian momentum spotlight its edge as investors weigh upside against Cresco Labs' slower growth.
  Nov 21, 2025
• Tilray Brands Stock Has Rallied 110% in Just 6 Months. Can Its Rally Keep Going?
  When there's talk of marijuana reform in the U.S., Tilray Brands is one stock that typically takes off.
  Nov 21, 2025
• Is There Now an Opportunity in Tilray After Recent 34% Share Price Drop?
  Wondering if Tilray Brands is undervalued right now? You are not alone, especially with the stock drawing attention from investors looking for the next overlooked bargain in cannabis and consumer packaged goods. Shares of Tilray have dropped sharply, down 20.2% in the past week and 34.0% over the last month. This decline has caught the eye of opportunistic buyers and prompted some to question whether risks have grown or opportunity is brewing. Much of this recent volatility follows Tilray’s...
  Nov 19, 2025
• Tilray Brands Extends Profit Momentum With Strong Q1 Results
  TLRY posts a sharp profitability turnaround in Q1 as cost control, efficiency gains and portfolio optimization boost results.
  Nov 18, 2025
• Tilray Brands Publishes New Investor Presentation Highlighting Leadership Across Beverage, Cannabis and Wellness Industries, Showcasing Its Global Growth Strategy and Transformation into a Diversified CPG Powerhouse Shaping the Future of Consumer Products
  NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray Brands”, “Tilray” or “the Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the beverage, cannabis and wellness industries, today announced the release of its updated investor presentation, outlining the Company’s strategic growth roadmap, category diversification, and financial performance milestones across its global platform. The presentation highlights Tilray
  Nov 17, 2025
• Why Tilray (TLRY) Stock Is Down Today
  Shares of cannabis company Tilray Brands (NASDAQ:TLRY) fell 1.8% in the morning session after the U.S. government passed a spending bill that included provisions to re-criminalize certain hemp-derived THC products.
  Nov 14, 2025
• 10 Barrel Pub Beer Taps Big Buck Hunter for Epic Cheap Fun Hunting SZN – Limited Edition Cans, Dive Bar Prizes, and $10,000 Arcade Giveaway Ignite Pacific Northwest
  Two Dive Bar Legends Team Up for a Season of Big Game, Cold Beer, and Exclusive PrizesPORTLAND, Ore., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Pub Beer, the affordable craft brand by 10 Barrel—a part of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY) has teamed up with the iconic arcade game Big Buck Hunter to launch Cheap Fun Hunting SZN. This collaboration celebrates the season with an exclusive limited-edition merchandise collection, a first-ever redesign of the Pub Beer can, and a sweepstakes feat
  Nov 13, 2025
• Cannabis Stocks Slide After U.S. Moves to Tighten Hemp Rules in Shutdown Deal
  Cannabis-linked shares fell Wednesday after the U.S. government funding bill to end the shutdown included language tightening rules on hemp-derived THC products. Shares of cannabis company Tilray Brands (TLRY) dropped 4.
  Nov 12, 2025
• 1 of Wall Street’s Favorite Stock to Own for Decades and 2 We Question
  Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings, partly because their firms often seek other business from the same companies they cover.
  Nov 11, 2025
• 'We Could Be Looking At A True Inflection Point For Cannabis,' Optimism Surges Among Investors Thanks To The 'Trump Effect'
  There have been some signals over the last several months that President Donald Trump may be considering a more permissive stance on cannabis. This potential for change at the federal level, dubbed "the Trump effect," has produced new levels of optimism among cannabis investors, CNBC reports. There are two major developments that have cannabis investors feeling hopeful about the industry. The first is Trump's openness to including coverage of CBD by Medicare. The second is the growing support in
  Nov 11, 2025
• Tilray Brands (NasdaqGS:TLRY): Examining Valuation Following a Recent Stretch of Volatility
  Tilray Brands (NasdaqGS:TLRY) has shown steady movement in recent trading, with shares climbing about 6% over the past week. Investors seem to be weighing the stock’s longer-term performance against its current price, particularly in light of recent swings in the cannabis sector. See our latest analysis for Tilray Brands. After a choppy stretch earlier this year, Tilray Brands' share price staged a comeback with a 5.65% gain over the past week, even as its 1-year total shareholder return...
  Nov 11, 2025
• Tilray Brands Condemns Misguided Prohibitionist Measures and Champions Responsible Hemp Regulations that Keep Consumers Safe and Businesses Thriving
  Tilray firmly stands with bipartisan lawmakers and industry partners calling for Congress to enact smart, responsible hemp regulations and a taxed pathway for hemp-derived THC products that ensures consumer safety, drives economic growth, and reflects what Americans want.NEW YORK, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray Brands” or “Tilray”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the beverage and hemp-wellness i
  Nov 11, 2025
• Aurora Cannabis: Medical Sales Boom Worldwide, Cash Flow to Swing Positive – Quarterly Update Report
  Download the Complete Report Here By Brandon Hornback Aurora Cannabis Inc. (NASDAQ: ACB) smoked another quarter, led by top-line growth, profitability, and disciplined capital allocation. And in fresh news, there’s positive cash flow right around the corner. Take a hit off this: The top line increased 11%, driven primarily by strong medical cannabis performance linked […]
  Nov 10, 2025
• Tilray Brands Extends Global Reach With Key Approvals and Launches
  TLRY expands its global medical cannabis footprint with key launches and approvals across Panama, Germany, Italy and Australia.
  Nov 10, 2025
• Cannabis Stock Tilray Brands Skyrockets 94.5%: Time to Buy, Sell or Hold?
  TLRY's 94.5% surge, record fiscal Q1 revenues, and expanding medical cannabis footprint fuel optimism amid global challenges.
  Nov 7, 2025
• Can Tilray (TLRY) Leverage Expanded Patient Access to Strengthen Its Canadian Medical Cannabis Position?
  Tilray Medical recently expanded its Canadian compassionate pricing program, raising the income eligibility threshold to CAD 65,000 and broadening affordability initiatives for seniors, first responders, pediatric patients, and veterans. This move highlights Tilray's ongoing commitment to patient access and support for vulnerable groups in the Canadian medical cannabis market. We'll explore how Tilray Medical’s increased support for patient accessibility could shape the company’s growth and...
  Nov 5, 2025
• Tilray Medical Sets the Standard for Compassionate Pricing, Broadening Access to Medical Cannabis for Patients, Seniors, First Responders, and Veterans Through Expanded Pricing Programs Across Canada
  LEAMINGTON, Ontario, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Tilray Medical a division of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY) and a global leader in medical cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, today announced significant updates to its Tilray Medical pricing programs in Canada, reinforcing its commitment to affordability, inclusivity, and patient support. These changes are designed to
  Nov 4, 2025
• 3 Stocks Under $10 We’re Skeptical Of
  Stocks under $10 pique our interest because they have room to grow (as well as the most affordable option contract premiums). That doesn’t mean they’re bargains though, and we urge investors to be careful as many have risky business models.
  Nov 3, 2025
• Tilray Brands Has Been Buying Bitcoin. Could It Help the Stock Surge Higher?
  Digital assets are a relatively small line on Tilray's balance sheet, but could get bigger in the future.
  Nov 3, 2025
• Tilray Brands Sets Sights on Asia: Bringing Award-Winning Craft Beers to Japan’s Premier American Craft Beer Experience Festival
  NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the beverage, cannabis and wellness industries, is bringing its celebrated craft beer brands to the heart of Asia. Tilray will debut select craft brands at the highly anticipated American Craft Beer Experience Festival in Japan, held November 22–24, 2025, in Tokyo’s vibrant Hibiya Park. Tilray’s participation in the American Craf
  Oct 30, 2025
• Redhook Brewing Launches Redhook 81, Celebrating Pacific Northwest Roots and the Spirit of Hard Work
  Redhook 81, a Cold One for Quittin’ TimeSEATTLE, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Redhook Brewing, creator of the hardest working beer in the fridge and a craft brand by Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the cannabis, beverage, and wellness industries, is proud to introduce Redhook 81, a crisp, no-nonsense light lager brewed for the end of the shift and the start of happy hour. Redhook 81 is a 4.2% ABV li
  Oct 23, 2025
• Tilray (NasdaqGS:TLRY): Exploring Valuation After U.S. Cannabis Reform Hopes and Strong Earnings Boost
  Tilray Brands (NasdaqGS:TLRY) is getting fresh attention after a run of upbeat news, fueled by speculation about U.S. cannabis rescheduling and a quarterly earnings report that outperformed expectations. Investors are watching these developments closely. See our latest analysis for Tilray Brands. Tilray's share price has staged a big comeback lately, surging more than 20% over the past month and more than doubling in the last 90 days as upbeat earnings and hopes for U.S. cannabis reform...
  Oct 23, 2025
• BC-Most Active Stocks
  HIVE Digital Technologies Ltd. 33,790,580 5.44
  Oct 22, 2025
• Tilray Brands, Inc. (TLRY): A Bull Case Theory
  We came across a bullish thesis on Tilray Brands, Inc. on Value investing subreddit by MarketFlux. In this article, we will summarize the bulls’ thesis on TLRY. Tilray Brands, Inc.’s share was trading at $2.1000 as of October 9th. TLRY’s trailing P/E was 57.50 according to Yahoo Finance. Tilray Brands (TLRY) has spent the past year executing […]
  Oct 22, 2025
• Tilray Brands Stock Is on Track for Its Best Year Since 2018. Has It Become a Good Buy?
  The cannabis stock is up 20% this year, and that's a phenomenal performance by its standards.
  Oct 22, 2025

TLRY Reviews

• LiquidLegend

  Dec 29, 2025

  $TLRY This one’s got the vibe of that friend who can’t stop talking about their garden—except it’s all about the green stuff.

  Buy

• CapitalRush

  Dec 29, 2025

  $TLRY This company is at the forefront of a rapidly evolving sector, leveraging innovative strategies to capture market share. Its commitment to sustainability and product development positions it well for future growth, making it a noteworthy player in the industry.

  Buy

• LiquidLegend

  Dec 29, 2025

  $TLRY This company is like your friend's fridge—full of good vibes and maybe a bit of green. Snack on their growth potential!

  Buy

• PnLReaper

  Dec 28, 2025

  $TLRY As the landscape of the cannabis industry evolves, this company is strategically positioned with a diverse product portfolio. Its focus on expanding market reach and enhancing brand recognition may contribute to long-term success.

  Buy

• TheTradingVerse

  Dec 28, 2025

  $TLRY Operating in the rapidly evolving cannabis market, this company is navigating regulatory challenges while exploring diverse product lines. Its innovative spirit may attract attention as the industry develops.

  Sell

• CodeAndCapital

  Dec 28, 2025

  $TLRY When your business is all about the green stuff, just make sure it’s not just in your wallet during the dry season!

  Sell

• VolatilityViper

  Dec 28, 2025

  $TLRY Their hype is higher than their actual products.

  Sell

• RiskDriver

  Dec 27, 2025

  $TLRY Operating in a rapidly evolving market, this company is at the forefront of cannabis innovation. Their focus on diversified product lines and international expansion initiatives indicates a forward-thinking approach that stands to benefit shareholders.

  Buy

• BullishVanguard

  Dec 27, 2025

  $TLRY Investing here is like hoping for a miracle.

  Sell

• WallStreetHex

  Dec 25, 2025

  $TLRY Operating within the dynamic cannabis industry, this firm is navigating regulatory challenges while exploring diverse product offerings. Its strategic initiatives may pave the way for future growth amidst evolving market conditions.

  Sell

• BearHunter

  Dec 25, 2025

  $TLRY This company is like that friend who brings snacks to a party! Always getting attention, and everyone wants a piece of the action.

  Buy

• TickerPhantom

  Dec 24, 2025

  $TLRY Operating in a rapidly evolving market, this company is leveraging trends in the cannabis industry to expand its product offerings. Their strategic acquisitions and commitment to quality could differentiate them in a competitive landscape.

  Buy

• BullRaid

  Dec 23, 2025

  $TLRY This one's riding on the coattails of a trend; how original.

  Sell

• RiskDriver

  Dec 23, 2025

  $TLRY As the cannabis market continues to expand, this company stands out with its diversified portfolio and strong brand presence. Its agility in product development positions it to capitalize on emerging trends.

  Buy

• BearWithMe

  Dec 22, 2025

  $TLRY Rolling with the green wave, they’re in the game to stay lit.

  Sell

• TradeProtocol

  Dec 22, 2025

  $TLRY This company is all about bringing good vibes. Just remember, chill doesn’t mean slack—stay groovy and productive!

  Buy

• AlphaVandal

  Dec 22, 2025

  $TLRY Stuck in a haze while the competition zooms ahead.

  Sell

• BullRaid

  Dec 21, 2025

  $TLRY This 'brand' is just high on its own hype.

  Sell

• RiskVandal

  Dec 21, 2025

  $TLRY In a market full of weeds, this one's barely growing.

  Sell

• QuantKnight

  Dec 21, 2025

  $TLRY In the ever-shifting landscape of cannabis, how long can they keep up with the competition? Each earnings report brings new anxiety! Will the next move ensure survival or lead to disaster?

  Sell

• MarginDagger

  Dec 21, 2025

  $TLRY In the ever-evolving cannabis industry, this company stands out with its strategic partnerships and diverse product offerings. A strong brand presence and expanding market share suggest a dynamic future ahead.

  Buy

• ShortSqueezeX

  Dec 21, 2025

  $TLRY Investing here is like planting a garden; you might get some funky flowers or just a patch of weeds. Fingers crossed for daisies!

  Sell

• BearHunter

  Dec 20, 2025

  $TLRY This stock is like that friend who always has snacks at the party. Everyone wants them around, but sometimes it gets a bit wild!

  Sell

• BullishMyth

  Dec 19, 2025

  $TLRY This cannabis giant is facing more scrutiny than ever! Will the high demand sustain, or is the market about to hit a wall? The stakes couldn't be higher!

  Sell

• WallStreetVandal

  Dec 19, 2025

  $TLRY Yet another weed stock claiming it will change the world. Sure.

  Sell

• GainsOverBrains

  Dec 19, 2025

  $TLRY This green giant’s got some serious hustle, keep an eye on it!

  Buy

• CapitalCreep

  Dec 19, 2025

  $TLRY Another overhyped cannabis venture destined to disappoint.

  Sell

• LazyQuant

  Dec 18, 2025

  $TLRY Budding ideas that are growing faster than my love for pizza. Who knew green could be this interesting?

  Buy

• FiscalFury

  Dec 18, 2025

  $TLRY Feeling a bit green? Maybe it’s time to spice up your life with some herbal options!

  Buy

• ByteBull

  Dec 18, 2025

  $TLRY This company is like that friend who's always ready to party—sometimes a little too enthusiastic, but hey, who doesn't love a good time?

  Buy

• MarginMyth

  Dec 18, 2025

  $TLRY The cannabis hype train left you behind; enjoy the ride down.

  Sell

• MarginMythic

  Dec 17, 2025

  $TLRY Amidst the market chaos, this one keeps attracting attention! What’s behind the hype? The uncertainty is palpable, and every twist could send shockwaves through the portfolio!

  Sell

• VolatilityStrike

  Dec 16, 2025

  $TLRY As a significant entity in the cannabis industry, this company is navigating regulatory changes and expanding its market presence. Their diverse product offerings aim to meet consumer demands in an evolving landscape.

  Sell

• ChartPilot

  Dec 16, 2025

  $TLRY Amidst the changing tides in the cannabis industry, uncertainty looms large. The stakes are high, and every move could make or break this contender's position in a fiercely competitive market!

  Sell

• PnLPhantom

  Dec 16, 2025

  $TLRY Facing an uphill battle in a rapidly shifting market, this stock keeps you guessing about its next move. It's a hard one to pin down!

  Sell

• TradingNomad

  Dec 15, 2025

  $TLRY The cannabis market feels like a rollercoaster; are you ready for the ups and downs that could leave investors reeling?

  Sell

• LazyQuant

  Dec 15, 2025

  $TLRY Like your friend who always suggests tacos for dinner—this company knows how to make things fun and trendy!

  Sell

• FiscalFury

  Dec 14, 2025

  $TLRY If this stock were a pizza, it would be loaded with toppings and always a crowd-pleaser. Can't resist those vibes!

  Buy

• WallStreetWraith

  Dec 13, 2025

  $TLRY Another overhyped cannabis mess waiting to crash.

  Sell

• OptionNomad

  Dec 13, 2025

  $TLRY Strong downward imbalance.

  Sell

• BearBreaker

  Dec 13, 2025

  $TLRY Bearish pressure accelerating quickly.

  Sell

• DividendDemon

  Dec 12, 2025

  $TLRY This company is like kale—super trendy in health circles, but can be a bit of an acquired taste for some investors!

  Sell

• DividendGhost

  Dec 12, 2025

  $TLRY With the market constantly shifting and regulatory hurdles looming, it's a nerve-wracking ride for investors. The potential upside is tantalizing, but the risk feels palpable. Can you handle the pressure?

  Sell

• TradeGoblin

  Dec 12, 2025

  $TLRY Great follow-through from buyers today.

  Buy

• HODLzilla

  Dec 11, 2025

  $TLRY Cannabis scene's buzzing, these folks could roll big!

  Buy

• StonkPhantom

  Dec 11, 2025

  $TLRY Strong fundamentals backing this move.

  Buy

• TradeProtocol

  Dec 11, 2025

  $TLRY Bearish volatility spike incoming.

  Sell

• CodeAndCapital

  Dec 11, 2025

  $TLRY Steep downside movement incoming.

  Sell

• OptionShadow

  Dec 11, 2025

  $TLRY Bulls defending every drop.

  Buy

• TheChartCode

  Dec 11, 2025

  $TLRY Technical setup favors sellers.

  Sell

• RiskVandal

  Dec 11, 2025

  $TLRY Large bids appearing out of nowhere.

  Buy

• ByteBull

  Dec 11, 2025

  $TLRY This company is like the cool kid at the party, but everyone is still figuring out if they just brought chips or something a little more... spirited.

  Buy

• ShortCircuit

  Dec 10, 2025

  $TLRY This one’s been more disappointing than my last date.

  Sell

• CapitalHex

  Dec 10, 2025

  $TLRY In a dynamic industry characterized by regulatory changes and consumer shifts, this company is navigating challenges while expanding its product offerings. Its strategy reflects a keen awareness of market trends.

  Sell

• TheEarningsBeast

  Dec 9, 2025

  $TLRY Failed support retest = bearish.

  Sell

• BullishBerserker

  Dec 9, 2025

  $TLRY Downside continuation formation.

  Sell

• StockNova

  Dec 8, 2025

  $TLRY In the rapidly growing cannabis market, this company has established a strong brand presence and diversified product offerings. Their potential for expansion in new markets could enhance shareholder value significantly.

  Buy

• OptionMatrix

  Dec 8, 2025

  $TLRY In the rapidly evolving cannabis sector, this company has made significant strides in establishing a diverse product range and global reach. Its adaptive strategies and focus on market expansion reflect strong growth potential.

  Buy

• BagholderPrime

  Dec 8, 2025

  $TLRY This company is like that one friend who’s always just a little too chill—making things fun, but sometimes too relaxed for comfort!

  Sell

• RiskRanger

  Dec 8, 2025

  $TLRY Feels like a chill day at the beach—good vibes and a little sunshine, but don’t forget the sunscreen!

  Sell

• CapitalCreep

  Dec 8, 2025

  $TLRY Still waiting for this cannabis dream to smoke itself out.

  Sell

• BearFighter

  Dec 7, 2025

  $TLRY Weed stocks? More like weed out your cash.

  Sell

• PixelBroker

  Dec 6, 2025

  $TLRY This brand knows all about high times—just remember to keep your snacks nearby for the full experience!

  Buy

• ShortRaid

  Dec 5, 2025

  $TLRY In the rapidly changing cannabis sector, this company is strategically positioning itself for long-term success. Their emphasis on quality and compliance could set a standard in an increasingly competitive market.

  Buy

• MarginMythic

  Dec 5, 2025

  $TLRY With this cannabis company's shares swinging wildly, every news cycle feels like a high-stakes game! Can it stay relevant in a saturated market, or will it be another smoke and mirrors?

  Sell

• OptionOutlaw

  Dec 5, 2025

  $TLRY This stock's ups and downs could make a rollercoaster jealous.

  Sell

• CryptoCobra

  Dec 5, 2025

  $TLRY This stock is like a chill weekend—relaxing and full of potential 'high' moments!

  Buy

• ChartPhantom

  Dec 4, 2025

  $TLRY This stock is riding the rollercoaster of life - full of ups, downs, and that thrilling drop when you least expect it!

  Sell

• MarketGlitch

  Dec 4, 2025

  $TLRY Market sentiment shifting positive.

  Buy

• WallStreetWraith

  Dec 4, 2025

  $TLRY Upside breakout probability increasing.

  Buy

• GainVector

  Dec 4, 2025

  $TLRY This company operates in a rapidly evolving industry, leveraging market trends to expand its portfolio. Its strategic initiatives position it well amid regulatory changes.

  Sell

• RiskWraith

  Dec 4, 2025

  $TLRY Strong momentum going into tomorrow.

  Buy

• GainSurge

  Dec 4, 2025

  $TLRY Strong reversal candle printed today.

  Buy

• CryptoCobra

  Dec 4, 2025

  $TLRY This company is the cool kid at the party, bringing all the vibes and good times! 🌿🎉

  Buy

• TradingNomad

  Dec 3, 2025

  $TLRY This industry is wild! Recent trends suggest potential growth, but the market can turn on a dime. Is this momentary hype, or is there real substance behind the buzz? It's a tense waiting game.

  Buy

• TradeReckoner

  Dec 2, 2025

  $TLRY This brand is all smoke and mirrors.

  Sell

• BearHunter

  Dec 2, 2025

  $TLRY They’re into growing plants that make you feel chill – the perfect recipe for a laid-back weekend and some great munchies!

  Buy

• VolatilityStrike

  Dec 2, 2025

  $TLRY This cannabis company is at the forefront of a rapidly evolving industry, showcasing strong branding and a diverse product offering. Ongoing regulatory changes may impact their growth trajectory.

  Sell

• CashOverload

  Dec 1, 2025

  $TLRY Seems like the hype train derailed long ago.

  Sell

• CodeTrader

  Dec 1, 2025

  $TLRY In the unpredictable world of cannabis, this company's next move could cause shockwaves. The uncertainty is thick, and investors are feeling the heat!

  Sell

• MarginMyth

  Nov 30, 2025

  $TLRY Another cannabis company trying to convince you it’s not a dumpster fire.

  Sell

• TheMemeInvestor

  Nov 30, 2025

  $TLRY In a green rush, but gotta watch out for the dips.

  Sell

• ChartPhantom

  Nov 30, 2025

  $TLRY Investing in this feels like trying to grow a plant—sometimes it flourishes, and other times it’s just a sad little twig.

  Buy

• WallStreetVandal

  Nov 30, 2025

  $TLRY Another overhyped plant that won't blossom.

  Sell

• PortfolioFreak

  Nov 29, 2025

  $TLRY With the ever-changing landscape of cannabis regulations, this company is undoubtedly in a whirlwind, and the uncertainty creates a tense atmosphere for investors waiting for clarity.

  Sell

• CryptoCobra

  Nov 29, 2025

  $TLRY This company is like the chill vibe at a party—always bringing the fun and relaxation!

  Buy

• OptionRogue

  Nov 28, 2025

  $TLRY Operating in the rapidly evolving cannabis industry, this company is leveraging unique market positioning and product diversification. Its innovative strategies are geared toward capturing a growing consumer base.

  Buy

• PnLPhantom

  Nov 28, 2025

  $TLRY It’s a wild game of chance! Each day feels like spinning the wheel to see if you land on fortune or disaster—my stomach can't take much more!

  Sell

• MarginMythic

  Nov 26, 2025

  $TLRY The cannabis market is a rollercoaster! With regulatory hurdles and market saturation, will this company find its foothold or be left in the dust?

  Sell

• HedgeKnight

  Nov 26, 2025

  $TLRY This stock is like a chill friend who always brings snacks to the party—super popular and keeps things interesting!

  Buy

• BearHunter

  Nov 26, 2025

  $TLRY This brand is basically the cool kid at school who’s always got the latest trends, but you’re not sure if they’re legit!

  Buy

• RiskRaider

  Nov 25, 2025

  $TLRY Just another overhyped weed venture lost in a haze.

  Sell

• EarningsSync

  Nov 24, 2025

  $TLRY This sector is saturated with volatility and fervent speculation; each day feels like a rollercoaster ride. Anticipate the twists and turns, as fortunes could change in the blink of an eye!

  Buy

• WallStreetHex

  Nov 23, 2025

  $TLRY This company is positioned at the intersection of health and lifestyle, leveraging evolving consumer trends. Its commitment to sustainable practices and product innovation suggests a strong potential for future growth.

  Buy

• ShortSavage

  Nov 23, 2025

  $TLRY The cannabis market is a swirling storm of regulations and competition! Can this company navigate the chaos and come out on top?

  Sell

• VolatilityNomad

  Nov 23, 2025

  $TLRY This plant-based hype isn't worth the high.

  Sell

• DividendHunter

  Nov 22, 2025

  $TLRY Just a high-flying mess with no real landing gear.

  Sell

• VolatileViking

  Nov 22, 2025

  $TLRY Imagine a party where everyone’s chill and having a good time. This company might just have the secret ingredient!

  Sell

• TradePulse

  Nov 22, 2025

  $TLRY Diving into this stock feels like a plunge into a chaotic market where hype meets reality! The ups and downs are dizzying, leaving investors with a mix of excitement and anxiety.

  Sell

• CashOverload

  Nov 22, 2025

  $TLRY The highs might seduce you, but the lows are brutal.

  Sell

• TradeProtocol

  Nov 21, 2025

  $TLRY This company is like the cool kid at school—always has the best snacks! Just be careful, it might leave you a little dizzy.

  Sell

• BullishSniper

  Nov 21, 2025

  $TLRY Imagine if this stock were a trendy coffee shop – everyone would be raving about it on social media!

  Buy

• AlphaRogue

  Nov 21, 2025

  $TLRY They're the cool kid at the party bringing all the snacks! Who doesn't love a good time with some chill vibes?

  Buy

• RiskProtocol

  Nov 20, 2025

  $TLRY The cannabis sector is buzzing with potential, but volatility is the name of the game. Market trends are unpredictable, and headlines can change overnight. Are we riding high or about to crash?

  Buy

• CodeAndCapital

  Nov 20, 2025

  $TLRY Imagine this stock as a chill vibe at the beach—just kicking back and enjoying life. Totally groovy!

  Buy

• StockSpecter

  Nov 19, 2025

  $TLRY Getting high on hopes, but the reality's a real buzzkill.

  Sell

• CapitalFrame

  Nov 19, 2025

  $TLRY Navigating the evolving landscape of the cannabis industry, this company is diversifying its portfolio and exploring new avenues for revenue. Their adaptability could lead to robust growth in the coming years.

  Buy

• GainsOverBrains

  Nov 18, 2025

  $TLRY The green wave is strong, feel the vibes rolling in heavy!

  Buy

• MarginMarauder

  Nov 18, 2025

  $TLRY They’re rolling in the green, and it’s not just envy! Perfect for chill vibes but may lead to munchies!

  Buy

• PixelBroker

  Nov 18, 2025

  $TLRY If you thought a chill vibe was all about the couch and snacks, wait till you see where this one’s headed!

  Buy

• AlphaWave

  Nov 18, 2025

  $TLRY In the booming cannabis market, there's no room for hesitation. The competition is fierce, and this company needs to stand out to avoid being left in the dust.

  Buy

• AlphaRogue

  Nov 17, 2025

  $TLRY This stock is like a chill hangout spot—great vibes, but sometimes you wonder if they really have it all together!

  Buy

• PortfolioFreak

  Nov 17, 2025

  $TLRY The highs are exhilarating, but the lows can be gut-wrenching! This space is buzzing with excitement and uncertainty, making it a tough challenge for any investor. Are you feeling brave?

  Sell

• MarketWolf

  Nov 17, 2025

  $TLRY The cannabis sector is buzzing with expectations, but with shifting regulations and market saturation looming, is it a bright future or a risky gamble? Tread carefully through this green maze!

  Sell

• MarketSavage

  Nov 17, 2025

  $TLRY Perpetually chasing trends that never quite hit.

  Sell

• BearFighter

  Nov 17, 2025

  $TLRY Cannabis buzz might not cover up the reality of its struggles.

  Sell

• BuyLowBoi

  Nov 15, 2025

  $TLRY They rollin' with the green, keep your eyes peeled!

  Buy

• MarginMarauder

  Nov 15, 2025

  $TLRY If stocks were snacks, this one would be a pot brownie: a little weird, but everyone’s talking about it and it just might make you feel really good!

  Sell

• MarginMarauder

  Nov 15, 2025

  $TLRY This stock has the munchies for growth! Who knew something could be so chill and still make waves?

  Buy

• AlphaStriker

  Nov 14, 2025

  $TLRY This brand is as trendy as last year’s fashion.

  Sell

• TradeMatrix

  Nov 13, 2025

  $TLRY With regulations changing faster than the wind, is there a way to stay ahead in this volatile market? It’s a gamble every time!

  Sell

• PaperHandsGone

  Nov 13, 2025

  $TLRY Chillin’ in the green scene, vibes are up but keep it cool!

  Sell

• MarketGlitch

  Nov 13, 2025

  $TLRY Every time I check, it feels like I’m gambling! The volatility is palpable, and making sense of it all requires a crystal ball or a strong drink.

  Sell

• WallStreetRogue

  Nov 13, 2025

  $TLRY The cannabis sector is a rollercoaster, and this stock is right along for the wild ride. Will it hit a high point or plummet back down? My heart’s racing!

  Buy

• TradeFrenzy

  Nov 13, 2025

  $TLRY Just another overcooked cannabis dream with no substance.

  Sell

• TraderFury

  Nov 12, 2025

  $TLRY The cannabis market is a wild ride, with highs and lows that can shock investors! Can this company navigate the legal labyrinth and thrive where others stumble?

  Buy

• StockSpecter

  Nov 12, 2025

  $TLRY Another overhyped trend that’s lost its buzz and left investors dizzy.

  Sell

• TradeBlaze

  Nov 12, 2025

  $TLRY In the evolving landscape of cannabis products, this company's diverse portfolio and strong brand presence position it favorably. Its commitment to quality and innovation reflects a promising future in a growing market.

  Buy

• DividendVandal

  Nov 12, 2025

  $TLRY In the evolving landscape of cannabinoid products, this firm is positioned to capitalize on emerging trends. Their diversified approach to the market could drive growth in both consumer and medicinal segments.

  Buy

• ChartFang

  Nov 10, 2025

  $TLRY As the cannabis industry evolves, this company stands out with its diversified portfolio and commitment to research, positioning itself well for future growth opportunities.

  Buy

• StockSpecter

  Nov 10, 2025

  $TLRY The only high this stock knows is its volatility.

  Sell

• YOLOTrader

  Nov 10, 2025

  $TLRY This brand is like the chill friend who always brings the good vibes to the hangout!

  Buy

• MarketMemeLord

  Nov 10, 2025

  $TLRY This green giant's got some serious vibe, watch it rise like dough!

  Buy

• BuyTheDipBro

  Nov 10, 2025

  $TLRY Feeling groovy with the green scene, man! Let’s light it up!

  Buy

• BearishBoi

  Nov 9, 2025

  $TLRY If stocks were snacks, this one would be the trendy health bar everyone talks about—good vibes, but does it really fill you up?

  Sell

• GammaSlayer

  Nov 9, 2025

  $TLRY This one's floundering like a fish out of water.

  Sell

• HoldTheLine

  Nov 9, 2025

  $TLRY Rolling with the trends, just watch them elevate, fam.

  Buy

• ShortSavior

  Nov 9, 2025

  $TLRY In a sticky situation; hard to see a way out.

  Sell

• StockStrider

  Nov 9, 2025

  $TLRY As a key player in the cannabis industry, this company is navigating regulatory landscapes while expanding its product offerings. Its focus on innovation and market expansion highlights a proactive approach in a constantly changing sector.

  Buy